RC-01 demonstrates promising efficacy in murine pneumonia and urinary tract infection models July 2, 2019
Phase III study of sildenafil in newborns with PPHN does not meet primary efficacy endpoint July 1, 2019
Vedanta's live biotherapeutic product candidate VE-416 begins phase Ib/II study for peanut allergy July 1, 2019
RSS